Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Life Technologies Teams with Universitry of North Texas

Published: Thursday, June 21, 2012
Last Updated: Thursday, June 21, 2012
Bookmark and Share
University Advances Forensic Research by Investing in Semiconductor DNA Sequencing Technology.

Life Technologies Corporation announced a collaboration with the University of North Texas Health Science Center's  Institute of Applied Genetics utilizing the company's Ion Personal Genome Machine® (PGM™) system to further their research, development, and implementation of best technologies in forensic DNA analyses.

The Ion PGM™ Sequencer does not rely on light for sequencing, but rather translates chemical sequencing information directly into digital form by using semiconductor technology.  The result — sequencing that is simpler, faster, accurate, and more cost effective, than any other technology currently available.

"These are exciting times," said Dr. Bruce Budowle, Executive Director, Institute of Applied Genetics at the UNT Health Science Center.  "With the introduction of Life Technologies' Ion PGM™ Sequencer, application-oriented laboratories now have the sequencing power that has been the domain of large genome centers."  Added Budowle, "Massively parallel sequencing using an IonPGM™ Sequencer holds promise of advancing analyses to address forensic questions previously not believed feasible."

Both Drs. Budowle and Arthur Eisenberg, Professor and Chairman, Dept. of Forensic and Investigative Genetics at the UNT Health Science Center, will evaluate the use of the Ion PGM™ Sequencer for its utility and develop protocols on the system for a wide array of forensic identification applications, including missing persons identifications, mass disaster work, interpretations of complex mixtures and bio-defense.   The Ion PGM™ Sequencer enables the analysis of 96 samples in one run and has great potential in enabling forensic practitioners to obtain more information from the samples they currently process.

Training forensic analysts on the application of next generation sequencing will be a key output of the collaboration.  "The Ion PGM™ Sequencer could represent the next evolutionary stage in the field of Human Identification and Forensic Genetics," said Dr. Arthur Eisenberg.  "Exposing established and new forensic scientists to the latest technology enables them to begin thinking about the potential of how this new technology can be applied to the important work they do every day.  The Life Technologies Institute for Forensic Genetics, located at the UNTHSC at Ft. Worth, provides us the opportunity to begin to train scientists on how to utilize the latest technologies in real cases," added Eisenberg.

As the global leader in forensic and human identification testing solutions, the company believes this new technology provides new capabilities to law enforcement agencies throughout the world that will enable them to obtain more information from forensic samples.

"This collaboration enables our customers to access methods developed by the most experienced forensic experts in the world," said John Gerace, Head of Applied Sciences for Life Technologies.  "Life Technologies understands the needs of forensic customers throughout the world better than any other company and as a result, we deliver the world's best solutions.  This is why we're so proud to be able to offer Drs. Budowle and Eisenberg the latest technology that will one day potentially revolutionize how forensics is performed in labs around the world."

For over twenty-five years, Life Technologies has led the development and commercialization of DNA detection and analysis technologies, providing innovative Applied Biosystems® technologies that allow scientists to maximize their use of DNA in establishing identity and solving crimes. Today, we offer the most robust, reliable, and trusted forensic solutions for human identification (HID) testing—and we are the only company in the world that designs and validates its reagents, instruments, and data analysis software together as an integrated system for HID testing.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Life Technologies' Ion AmpliSeq™ Exome Program Adds 12 New Members
With more than 30 members the program is the largest network of next generation-based exome sequencing providers in the world.
Friday, December 20, 2013
KACST Partners with Life Tech in The Saudi Human Genome Program
Program aims to analyze 100,000 human genomes to identify the causes of disease in the population of the Kingdom of Saudi Arabia and the Arab world.
Monday, December 09, 2013
BGI Partners with Life Technologies
World's largest genome center to purchase 50 Ion Proton™ Sequencers from Life Technologies.
Tuesday, October 22, 2013
Life Technologies Expand Ion AmpliSeq™ Exome Certified Service Provider Program
Due to increased demand the program is expanding to include eleven new members.
Wednesday, October 09, 2013
TriCore Reference Laboratories Named First NGS Center of Excellence by Life Technologies
Collaborative partnership designed to accelerate clinical research in the Southwest using advanced NGS oncology panels.
Thursday, September 19, 2013
Life Technologies Signs Five-Year Agreement with the FDA
The agreement aims to accelerate and advance food safety testing of E. coli and Salmonella, two foodborne contaminants commonly associated with outbreaks and/or recalls.
Tuesday, July 30, 2013
Life Technologies to Collaborate with Merck Serono
Long-term collaboration is aimed at developing, obtaining regulatory approval and commercializing companion diagnostics for selected Merck Serono drug development programs.
Wednesday, July 17, 2013
Life Technologies Acquires Life Science Korea
The acquisition strengthens Life Tech's go-direct strategy in South Korea.
Friday, June 14, 2013
Roswell Park Cancer Institute Purchases Six Ion Torrent Sequencers
Life Technologies Corporation announced that the new Center for Personalized Medicine at Roswell Park Cancer Institute has purchased four Ion Proton™ sequencers and two Ion Personal Genome Machine™ sequencers.
Thursday, February 21, 2013
Life Technologies Bolsters its 60 Percent Market Share Lead in Benchtop Sequencers
More than 90 peer-reviewed papers and the world's largest online sequencing community reflects broad adoption of Ion Torrent™ technology.
Wednesday, February 20, 2013
Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Products
Life's Applied Biosystems Dx Genetic Analyzer and SeCore® kits constitute first sequence-based system cleared for HLA typing.
Tuesday, February 12, 2013
Boston Children's Hospital and Life Technologies Launch Claritas Genomics, a Clinical Genomics Company
Spinoff venture will develop genomic sequencing solutions utilizing Ion Torrent technology for clinical applications.
Thursday, January 10, 2013
Life Technologies Announces Third Quarter 2012 Results
Revenue for the third quarter was $911 million, a decrease of 1.9 percent over the $929 million reported for the third quarter of 2011. Excluding the impact of currency, revenue growth for the quarter was 1.4 percent compared to the same period of the prior year.
Monday, November 05, 2012
VelaDx Signs Agreement with Life Technologies to Develop IVD Tests on Ion PGM Sequencer
Semiconductor sequencing brings unprecedented power to diagnostic tests to transform personalized medicine.
Wednesday, October 10, 2012
Life Technologies Acquires Compendia Bioscience
Bioinformatics expertise will enable deeper engagement with established customer base of leading pharmaceutical companies.
Tuesday, October 09, 2012
Scientific News
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Viral Comparisons
ORNL team applies genomics expertise to analyze, map virus sequence database.
The Tree of Life — More Like A Bush
New species evolve whenever a lineage splits off into several. Because of this, the kinship between species is often described in terms of a ‘tree of life’, where every branch constitutes a species.
Ancient Origins of Deadly Lassa Virus Uncovered
Working as part of an international team in North America and West Africa, a researcher at The Scripps Research Institute (TSRI) has published new findings showing the ancient roots of the deadly Lassa virus, a relative of Ebola virus, and how Lassa virus has changed over time.
Furthering Data Analysis of Next-gen Sequencing to Facilitate Research
Researchers at Cincinnati Children's Hospital Medical Center have developed a user-friendly, integrated platform for analyzing the transcriptomic and epigenomic "big data.
Statistical Technique Helps Researchers Understand Tumor Makeup, Personalize Cancer Treatments
A new statistical method for analyzing next-generation sequencing (NGS) data that helps researchers study the genome of various organisms such as human tumors and could help bring about personalized cancer treatments has been unveiled.
‘Fishing Expedition’ Nets Nearly Tenfold Increase in Number of Sequenced Virus Genomes
Newly developed computational tool finds 12,500 genomes of viruses that infect microbes.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!